scispace - formally typeset
K

Ken Ishii

Researcher at International University of Health and Welfare

Publications -  593
Citations -  37498

Ken Ishii is an academic researcher from International University of Health and Welfare. The author has contributed to research in topics: Immune system & Innate immune system. The author has an hindex of 83, co-authored 537 publications receiving 33230 citations. Previous affiliations of Ken Ishii include Daiichi Sankyo & University of Tokyo.

Papers
More filters
Journal ArticleDOI

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

TL;DR: It is found that RIG-I is essential for the production of interferons in response to RNA viruses including paramyxoviruses, influenza virus and Japanese encephalitis virus, whereas MDA5 is critical for picornavirus detection.
Journal ArticleDOI

IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction

TL;DR: IPS-1 contained an N-terminal CARD-like structure that mediated interaction with the CARD of RIG-I and Mda5, which are cytoplasmic RNA helicases that sense viral infection and blocked interferon induction by virus infection.
Journal ArticleDOI

Interferon-|[alpha]| induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6

TL;DR: It is shown that TLR-mediated IFN-α induction requires the formation of a complex consisting of MyD88, TRAF6 and IRF7 as well as TRAF 6-dependent ubiquitination.
Journal ArticleDOI

Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury.

TL;DR: It is suggested that Stat3 is a key regulator of reactive astrocytes in the healing process after SCI, providing a potential target for intervention in the treatment of CNS injury.
Journal ArticleDOI

A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNA

TL;DR: It is shown that intracellular administration of double-stranded B-form DNA triggered antiviral responses including production of type I interferons and chemokines independently of Toll-like receptors or the helicase RIG-I.